Skip to content
★ Sign in to follow
SB

Susan B. Bayh

Executive
Emmis Communications CorpElevance Health, Inc.Curis IncMarina Biotech, Inc.Dendreon Corp
Total declarations
81
Companies
5
▲ Purchases (1 ops.)
€159k
▼ Sales (30 ops.)
€5.2M

Latest filing published 09 Jul 2019 for EMMIS COMMUNICATIONS CORP, €1,826.

Insider track record

Disclosed buys
1
Disclosed sells
30
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Susan B. Bayh: trading record in brief

Susan B. Bayh has filed trades across 5 companies (mainly through SEC (Form 4)), most often in Emmis Communications Corp, Dendreon Corp and Elevance Health, Inc. We count 81 filings; the first trade dates from 3 February 2006 and the latest from 8 July 2019.

In open-market terms, that means 1 purchase worth €159k on one side and 30 sales worth €5.2M on the other. Sales outweigh purchases by €5.0M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 33 share grants and 17 option exercises.

The newest entry dates from 9 July 2019: a share grant of €1,825, in Emmis Communications Corp. The most recent open-market purchase was published on 13 September 2011, 5,535 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Susan B. Bayh

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations77 total

25 of 77 declarations